Literature DB >> 14729736

Antibiotic-induced persistence of cytotoxic Staphylococcus aureus in non-phagocytic cells.

Oleg Krut1, Herdis Sommer, Martin Krönke.   

Abstract

OBJECTIVES: After infection of non-phagocytic cells, some Staphylococcus aureus strains are able to survive and kill their host cells. The purpose of this study was to determine the action of various antibiotics on the survival of host cells and/or intracellular S. aureus.
METHODS: Murine keratinocyte (PAM212) and fibroblast (mKSA) cell lines were infected with cytotoxic S. aureus and cultured in the presence of various antibiotics at graded concentrations. The viability of host cells was measured 24 h after infection. To determine the bacterial viability within host cells, cellular lysates were prepared and colony forming units were quantified using a spiral plater. Host cells infected with fluorescein isothiocyanate (FITC)-labelled S. aureus were analysed by flow cytometry and microscopy to determine the subcellular localization S. aureus.
RESULTS: Oxacillin, vancomycin, gentamicin, ciprofloxacin and trimethoprim/sulfamethoxazole did not rescue host cells from cell death induced by intracellular S. aureus. In contrast, linezolid, rifampicin, azithromycin, clindamycin, erythromycin and quinupristin/dalfopristin suppressed the cytotoxic action of S. aureus. After withdrawal of antibiotics, intracellular S. aureus regained cytotoxic activity and killed their host cells. Only rifampicin was able to eliminate intracellular S. aureus completely within 72 h. In contrast, clindamycin, azithromycin and linezolid induced a state of intracellular persistence of viable S. aureus.
CONCLUSIONS: Antibiotics commonly used for the management of S. aureus infections appear to create a niche for invasive intracellular S. aureus, which may play an important role for persistence and recurrence of infection. Because of its unique ability to eliminate intracellular S. aureus, rifampicin appears to be valuable for the treatment of invasive S. aureus infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14729736     DOI: 10.1093/jac/dkh076

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  20 in total

1.  Lysozyme activates Enterococcus faecium to induce necrotic cell death in macrophages.

Authors:  Sabine Gröbner; Evelyn Fritz; Friederike Schoch; Martin Schaller; Alexander C Berger; Michael Bitzer; Ingo B Autenrieth
Journal:  Cell Mol Life Sci       Date:  2010-05-11       Impact factor: 9.261

2.  Arylthiazole antibiotics targeting intracellular methicillin-resistant Staphylococcus aureus (MRSA) that interfere with bacterial cell wall synthesis.

Authors:  Islam Eid; Mohamed M Elsebaei; Haroon Mohammad; Mohamed Hagras; Christine E Peters; Youssef A Hegazy; Bruce Cooper; Joe Pogliano; Kit Pogliano; Hamada S Abulkhair; Mohamed N Seleem; Abdelrahman S Mayhoub
Journal:  Eur J Med Chem       Date:  2017-08-18       Impact factor: 6.514

3.  In vivo efficacy of anuran trypsin inhibitory peptides against staphylococcal skin infection and the impact of peptide cyclization.

Authors:  U Malik; O N Silva; I C M Fensterseifer; L Y Chan; R J Clark; O L Franco; N L Daly; D J Craik
Journal:  Antimicrob Agents Chemother       Date:  2015-01-26       Impact factor: 5.191

Review 4.  Mechanisms of Immune Evasion and Bone Tissue Colonization That Make Staphylococcus aureus the Primary Pathogen in Osteomyelitis.

Authors:  Gowrishankar Muthukrishnan; Elysia A Masters; John L Daiss; Edward M Schwarz
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

Review 5.  Immobilized antibiotics to prevent orthopaedic implant infections.

Authors:  Noreen J Hickok; Irving M Shapiro
Journal:  Adv Drug Deliv Rev       Date:  2012-04-04       Impact factor: 15.470

6.  Expression of lysostaphin in HeLa cells protects from host cell killing by intracellular Staphylococcus aureus.

Authors:  Marcus Klein; Martin Krönke; Oleg Krut
Journal:  Med Microbiol Immunol       Date:  2006-02-16       Impact factor: 3.402

7.  Restoration of susceptibility of intracellular methicillin-resistant Staphylococcus aureus to beta-lactams: comparison of strains, cells, and antibiotics.

Authors:  Sandrine Lemaire; Aurélie Olivier; Françoise Van Bambeke; Paul M Tulkens; Peter C Appelbaum; Youri Glupczynski
Journal:  Antimicrob Agents Chemother       Date:  2008-06-02       Impact factor: 5.191

8.  Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Mohamed M Elsebaei; Haroon Mohammad; Mohamed Abouf; Nader S Abutaleb; Youssef A Hegazy; Adel Ghiaty; Lu Chen; Jianan Zhang; Satish R Malwal; Eric Oldfield; Mohamed N Seleem; Abdelrahman S Mayhoub
Journal:  Eur J Med Chem       Date:  2018-02-12       Impact factor: 6.514

9.  Killing of Staphylococcus aureus in murine macrophages by chloroquine used alone and in combination with ciprofloxacin or azithromycin.

Authors:  Somrita Dey; Biswadev Bishayi
Journal:  J Inflamm Res       Date:  2015-01-22

10.  A global view of Staphylococcus aureus whole genome expression upon internalization in human epithelial cells.

Authors:  Christian Garzoni; Patrice Francois; Antoine Huyghe; Sabine Couzinet; Caroline Tapparel; Yvan Charbonnier; Adriana Renzoni; Sacha Lucchini; Daniel P Lew; Pierre Vaudaux; William L Kelley; Jacques Schrenzel
Journal:  BMC Genomics       Date:  2007-06-14       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.